A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy.

Abstract:

:Myotonic dystrophy is the most common form of adult-onset muscular dystrophy, originating in a CTG repeat expansion in the DMPK gene. The expanded CUG transcript sequesters MBNL1, a key regulator of alternative splicing, leading to the misregulation of numerous pre-mRNAs. We report an RNA-targeted agent as a possible lead compound for the treatment of myotonic dystrophy type 1 (DM1) that reveals both the promise and challenges for this type of small-molecule approach. The agent is a potent inhibitor of the MBNL1-rCUG complex with an inhibition constant (Ki ) of 25±8 nm, and is also relatively nontoxic to HeLa cells, able to dissolve nuclear foci, and correct the insulin receptor splicing defect in DM1 model cells. Moreover, treatment with this compound improves two separate disease phenotypes in a Drosophila model of DM1: adult external eye degeneration and larval crawling defect. However, the compound has a relatively low maximum tolerated dose in mice, and its cell uptake may be limited, providing insight into directions for future development.

journal_name

ChemMedChem

journal_title

ChemMedChem

authors

Luu LM,Nguyen L,Peng S,Lee J,Lee HY,Wong CH,Hergenrother PJ,Chan HY,Zimmerman SC

doi

10.1002/cmdc.201600081

subject

Has Abstract

pub_date

2016-07-05 00:00:00

pages

1428-35

issue

13

eissn

1860-7179

issn

1860-7187

journal_volume

11

pub_type

杂志文章
  • Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.

    abstract::There is an urgent need for new drugs for the treatment of tropical parasitic diseases such as human African trypanosomiasis, which is caused by Trypanosoma brucei. The enzyme trypanothione reductase (TryR) is a potential drug target within these organisms. Herein we report the screening of a 62,000 compound library a...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200900262

    authors: Spinks D,Shanks EJ,Cleghorn LA,McElroy S,Jones D,James D,Fairlamb AH,Frearson JA,Wyatt PG,Gilbert IH

    更新日期:2009-12-01 00:00:00

  • Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats.

    abstract::Silent Night: Antagonism of the orexin (or hypocretin) system has recently been identified as a novel mechanism for the treatment of insomnia. Herein, we describe discovery of a dual (OX(1)R/OX(2)R) orexin receptor antagonist featuring a 1,4-diazepane central constraint that blocks orexin signaling in vivo. In telemet...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200900069

    authors: Whitman DB,Cox CD,Breslin MJ,Brashear KM,Schreier JD,Bogusky MJ,Bednar RA,Lemaire W,Bruno JG,Hartman GD,Reiss DR,Harrell CM,Kraus RL,Li Y,Garson SL,Doran SM,Prueksaritanont T,Li C,Winrow CJ,Koblan KS,Renger JJ,C

    更新日期:2009-07-01 00:00:00

  • Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants.

    abstract::Herein we report the design, synthesis, X-ray structural, and biological studies of an exceptionally potent HIV-1 protease inhibitor, compound 5 ((3S,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl ((2S,3R)-4-((2-(cyclopropylamino)-N-isobutylbenzo[d]thiazole)-6-sulfonamido)-1-(3,5-difluorophenyl)-3-hydroxybutan-...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700824

    authors: Ghosh AK,Rao KV,Nyalapatla PR,Kovela S,Brindisi M,Osswald HL,Sekhara Reddy B,Agniswamy J,Wang YF,Aoki M,Hattori SI,Weber IT,Mitsuya H

    更新日期:2018-04-23 00:00:00

  • Drug discovery alliances in India--indications, targets, and new chemical entities.

    abstract::Global pharmaceutical and biotechnology companies have been building increasingly on the skills and services offered by Indian biotech companies through strategic collaborative partnerships and alliances to fuel their in-house discovery and development pipelines. With the exception of generic press releases, however, ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300341

    authors: Differding E

    更新日期:2014-01-01 00:00:00

  • Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparum.

    abstract::A library of 40,000 compounds was screened for inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) protein from Arabidopsis thaliana using a photometric assay. A thiazolopyrimidine derivative resulting from the high-throughput screen was found to inhibit the IspF proteins of Mycobacterium tuberculosi...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201000083

    authors: Geist JG,Lauw S,Illarionova V,Illarionov B,Fischer M,Gräwert T,Rohdich F,Eisenreich W,Kaiser J,Groll M,Scheurer C,Wittlin S,Alonso-Gómez JL,Schweizer WB,Bacher A,Diederich F

    更新日期:2010-07-05 00:00:00

  • A Double Prodrug with Improved Membrane Permeability over the Parent Chelator HBED Provides Superior Cytoprotection against Hydrogen Peroxide.

    abstract::The clinical use of N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED) has been hindered by its lack of bioavailability. N,N'-bis(2-boronic pinacol ester benzyl)ethylenediamine-N,N'-diacetic acid methyl, ethyl, and isopropyl esters 7 a-c, respectively, and their dimesylate salts 8 a-c, are double prodr...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600197

    authors: Thiele NA,Sloan KB

    更新日期:2016-08-05 00:00:00

  • Model systems for activation of nucleic acid encoded prodrugs.

    abstract::The development of more selective chemotherapeutic agents for benign treatments of malicious diseases is highly desirable. In recent years model systems for the release of small molecule drugs from nucleic acid conjugates by templated chemical or photochemical reactions have been designed. Common for these systems is ...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.200700013

    authors: Jacobsen MF,Cló E,Mokhir A,Gothelf KV

    更新日期:2007-06-01 00:00:00

  • Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase.

    abstract::The development and progression of chronic complications in diabetic patients, such as retinopathy, nephropathy, neuropathy, cataracts, and stroke, are related to the activation and/or overexpression of aldose reductase (ALR2), which is a member of the aldo-keto reductase superfamily. A structure-activity relationship...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200386

    authors: Zhang S,Chen X,Parveen S,Hussain S,Yang Y,Jing C,Zhu C

    更新日期:2013-04-01 00:00:00

  • Mapping the catechol binding site in dopamine D₁ receptors: synthesis and evaluation of two parallel series of bicyclic dopamine analogues.

    abstract::A novel class of isochroman dopamine analogues, originally reported by Abbott Laboratories, have >100-fold selectivity for D₁-like over D₂-like receptors. We synthesized a parallel series of chroman compounds and showed that repositioning the oxygen atom in the heterocyclic ring decreases potency and confers D₂-like r...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201100010

    authors: Bonner LA,Laban U,Chemel BR,Juncosa JI,Lill MA,Watts VJ,Nichols DE

    更新日期:2011-06-06 00:00:00

  • Structure-Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR.

    abstract::Following the discovery of a type III allosteric modulator of cyclin-dependent kinase 2 (CDK2) characterized by a hexahydrocyclopenta[c]quinolone scaffold, three different series of its derivatives were synthesized and biologically evaluated. Docking of the synthesized compounds into the allosteric pocket of CDK2 allo...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800687

    authors: Carlino L,Christodoulou MS,Restelli V,Caporuscio F,Foschi F,Semrau MS,Costanzi E,Tinivella A,Pinzi L,Lo Presti L,Battistutta R,Storici P,Broggini M,Passarella D,Rastelli G

    更新日期:2018-12-20 00:00:00

  • Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates.

    abstract::The disruption of aberrant protein-protein interactions (PPIs) with synthetic agents remains a challenging goal in contemporary medicinal chemistry but some progress has been made. One such dysregulated PPI is that between the anti-apoptotic Bcl-2 proteins, including myeloid cell leukemia-1 (Mcl-1), and the α-helical ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201500461

    authors: Drennen B,Scheenstra JA,Yap JL,Chen L,Lanning ME,Roth BM,Wilder PT,Fletcher S

    更新日期:2016-04-19 00:00:00

  • Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug-resistant HIV-1 reverse transcriptase mutants.

    abstract::We recently reported the synthesis and biological evaluation of a novel series of 5-alkyl-2-(N,N-disubstituted)amino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones (F(2)-N,N-DABOs). These compounds are highly active against both wild-type HIV-1 and the K103N, Y181C, and Y188L mutant strains. Herein we pre...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800051

    authors: Samuele A,Facchini M,Rotili D,Mai A,Artico M,Armand-Ugón M,Esté JA,Maga G

    更新日期:2008-09-01 00:00:00

  • Molecular Hybridization Tools in the Development of Furoxan-Based NO-Donor Prodrugs.

    abstract::The molecular hybridization of different compounds with known pharmacological activity is a particularly prominent approach for the design of potential drugs with improved pharmacokinetic profiles. Much attention over the last decade has been focused on the synthesis of hybrid structures with a nitric oxide (NO)-donor...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.201700113

    authors: Fershtat LL,Makhova NN

    更新日期:2017-05-09 00:00:00

  • A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?

    abstract::Having oxaliplatin as archetype, several platinum complexes with a carbohydrate moiety resembling the cyclohexane-1,2-diamine ligand of oxaliplatin have been prepared. As leaving groups, the anionic ligands iodide, oxalate, and malonate were utilized, and for comparison purposes the chloro complex was employed. All co...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600279

    authors: Berger I,Nazarov AA,Hartinger CG,Groessl M,Valiahdi SM,Jakupec MA,Keppler BK

    更新日期:2007-04-01 00:00:00

  • The potential of P1 site alterations in peptidomimetic protease inhibitors as suggested by virtual screening and explored by the use of C-C-coupling reagents.

    abstract::A synthetic concept is presented that allows the construction of peptide isostere libraries through polymer-supported C-acylation reactions. A phosphorane linker reagent is used as a carbanion equivalent; by employing MSNT as a coupling reagent, the C-acylation can be conducted without racemization. Diastereoselective...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200500027

    authors: Weik S,Luksch T,Evers A,Böttcher J,Sotriffer CA,Hasilik A,Löffler HG,Klebe G,Rademann J

    更新日期:2006-04-01 00:00:00

  • Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration.

    abstract::The histone deacetylase (HDAC) family is a promising drug target class owing to the importance of these enzymes in a variety of cellular processes. Docking studies were conducted to identify novel HDAC inhibitors. Subtle modifications in the recognition domain were introduced into a series of chlamydocin analogues, an...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300372

    authors: Wang S,Li X,Wei Y,Xiu Z,Nishino N

    更新日期:2014-03-01 00:00:00

  • Carbonic anhydrase inhibitors: binding of indanesulfonamides to the human isoform II.

    abstract::Indanesulfonamides are interesting lead compounds for designing selective inhibitors of the different isoforms of the zinc enzyme Carbonic Anhydrase (CA). Herein, we report for the first time the X-ray crystal structure of two such derivatives, namely indane-5-sulfonamide and indane-2-valproylamido-5-sulfonamide, in c...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200700274

    authors: D'Ambrosio K,Masereel B,Thiry A,Scozzafava A,Supuran CT,De Simone G

    更新日期:2008-03-01 00:00:00

  • Guanidinylated dendritic molecular transporters: prospective drug delivery systems and application in cell transfection.

    abstract::In the present review the crucial role of the guanidinium functional group in facilitating the transport of dendritic polymers through liposomal and cell membranes is discussed, along with other structural features of guanidinylated dendritic polymers that fine-tune their transport properties, and even determine their...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.200800190

    authors: Theodossiou TA,Pantos A,Tsogas I,Paleos CM

    更新日期:2008-11-01 00:00:00

  • Indolicidin targets duplex DNA: structural and mechanistic insight through a combination of spectroscopy and microscopy.

    abstract::Indolicidin (IR13), a 13-residue antimicrobial peptide from the cathelicidin family, is known to exhibit a broad spectrum of antimicrobial activity against various microorganisms. This peptide inhibits bacterial DNA synthesis resulting in cell filamentation. However, the precise mechanism remains unclear and requires ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402215

    authors: Ghosh A,Kar RK,Jana J,Saha A,Jana B,Krishnamoorthy J,Kumar D,Ghosh S,Chatterjee S,Bhunia A

    更新日期:2014-09-01 00:00:00

  • Artemisinin-polypyrrole conjugates: synthesis, DNA binding studies and preliminary antiproliferative evaluation.

    abstract::Greater than the sum of its parts: Artemisinins are currently in phase I-II clinical trials against breast, colorectal and non-small-cell lung cancers. In an attempt to offer increased specificity, a series of hybrid artemisinin-polypyrrole minor groove binder conjugates are described. DNA binding/modelling studies an...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200536

    authors: La Pensée L,Sabbani S,Sharma R,Bhamra I,Shore E,Chadwick AE,Berry NG,Firman J,Araujo NC,Cabral L,Cristiano ML,Bateman C,Janneh O,Gavrila A,Wu YH,Hussain A,Ward SA,Stocks PA,Cosstick R,O'Neill PM

    更新日期:2013-05-01 00:00:00

  • A New Lead Identification Strategy: Screening an sp3 -rich and Lead-like Compound Library Composed of 7-Azanorbornane Derivatives.

    abstract::Although the advantages of sp3 -rich, sterically complicated molecules in drug development have been pointed out, modern screening libraries are filled with planar, sp2 -rich components. Compounds that are sp3 -rich are difficult to synthesize, and thus we aimed to invent an efficient method to construct sp3 -rich lib...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900398

    authors: Karaki F,Umemoto S,Ashizawa K,Oki T,Sato N,Ogino T,Ishibashi N,Someya R,Miyano K,Hirayama S,Uezono Y,Fujii H

    更新日期:2019-11-06 00:00:00

  • Oral Administration of Peptide-Based Drugs: Beyond Lipinski's Rule.

    abstract::The use of peptides in therapy presents several limitations, from physicochemical characteristics to inadequate pharmacokinetic profiles for oral absorption. As peptides are gaining importance in the therapeutic arsenal, there is an increasing need to rationalize the main characteristics of this compound class in the ...

    journal_title:ChemMedChem

    pub_type: 杂志文章,评审

    doi:10.1002/cmdc.201600288

    authors: Santos GB,Ganesan A,Emery FS

    更新日期:2016-10-19 00:00:00

  • Fluorescent probes for rapid screening of potential drug-drug interactions at the CYP3A4 level.

    abstract::Steroid derivatives bearing fluorescent groups such as anthracene, dansyl, deazaflavin, and pyrene attached to C6 were synthesized. These compounds are unique inhibitors of cytochrome P450 3A4 (CYP3A4) and display similar IC(50) values in the microM range for the CYP3A4 substrates midazolam, testosterone, and nifedipi...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600300

    authors: Chougnet A,Grinkova Y,Ricard D,Sligar S,Woggon WD

    更新日期:2007-05-01 00:00:00

  • Targeting Steroidogenic Cytochromes P450 (CYPs) with 6-Substituted 1-Imidazolylmethylxanthones.

    abstract::Abnormally high corticosteroid levels are responsible for the onset of serious hormone-related diseases, and the inhibition of their biosynthesis by targeting cytochrome P450 (CYP) isoforms CYP11B1 and CYP11B2 has emerged as a promising strategy to restore healthy physiological levels of corticosteroids. With the aim ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600078

    authors: Gobbi S,Hu Q,Zimmer C,Belluti F,Rampa A,Hartmann RW,Bisi A

    更新日期:2016-08-19 00:00:00

  • Promiscuity and the conformational rearrangement of drug-like molecules: insight from the protein data bank.

    abstract::Selectivity is a central aspect of lead optimization in the drug discovery process. Medicinal chemists often try to decrease molecular flexibility to improve selectivity, given the common belief that the two are interdependent. To investigate the relationship between polypharmacology and conformational flexibility, we...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402389

    authors: He MW,Lee PS,Sweeney ZK

    更新日期:2015-02-01 00:00:00

  • Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazole Derivatives.

    abstract::Cellular chaperones that belong to the heat-shock protein 90 (Hsp90) family are a prerequisite for successful viral propagation for most viruses. The hepatitis C virus (HCV) uses Hsp90 for maturation, folding, and modification of viral proteins. Based on our previous discovery that marine alkaloid analogues with a 4,5...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800724

    authors: Lillsunde KE,Tomašič T,Schult P,Lohmann V,Kikelj D,Tammela P

    更新日期:2019-02-05 00:00:00

  • Preparation of a Salecan/poly(2-acrylamido-2-methylpropanosulfonic acid-co-[2-(methacryloxy)ethyl]trimethylammonium chloride) Semi-IPN Hydrogel for Drug Delivery.

    abstract::Salecan is a water-soluble bacterial polysaccharide consisting of glucopyranosyl units linked by α-1,3 and β-1,3 glycosidic bonds. salecan is suitable for the development of hydrogels for biomedical applications, given its outstanding physicochemical and biological profiles. In this study we designed a new semi-interp...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600570

    authors: Qi X,Li J,Wei W,Su T,Zuo G,Pan X,Zhang J,Dong W

    更新日期:2017-01-20 00:00:00

  • N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity.

    abstract::From insects to cancer: N-Cyano sulfoximines were evaluated for COX inhibition and antiproliferative activity against a panel of cancer cell lines. The most active compound exhibited potent COX-2 inhibition, some selectivity for COX-2 over COX-1, only slight cytotoxicity towards healthy cells (HaCaT skin cells), and n...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200403

    authors: Park SJ,Baars H,Mersmann S,Buschmann H,Baron JM,Amann PM,Czaja K,Hollert H,Bluhm K,Redelstein R,Bolm C

    更新日期:2013-02-01 00:00:00

  • Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97-p47 complex.

    abstract::We previously found that p97 ATPase inhibitors 2-(2-amino-1H-benzo[d]imidazol-1-yl)-N-benzyl-8-methoxyquinazolin-4-amine (ML240) and 2-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-N-benzyl-5,6,7,8-tetrahydroquinazolin-4-amine (ML241) specifically target the D2 domain of wild-type p97. In addition, one of the major p97 cofactors,...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402420

    authors: Fang CJ,Gui L,Zhang X,Moen DR,Li K,Frankowski KJ,Lin HJ,Schoenen FJ,Chou TF

    更新日期:2015-01-01 00:00:00

  • Structure-activity relationship of trifluoromethyl-containing metallocenes: electrochemistry, lipophilicity, cytotoxicity, and ROS production.

    abstract::We report the synthesis of trifluoromethylated metallocenes (M=Fe, Ru) and related metal-free compounds for comparison of their biological properties with the aim to establish structure-activity relationships toward the anti-proliferative activity of this compound class. All new compounds were comprehensively characte...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402001

    authors: Maschke M,Alborzinia H,Lieb M,Wölfl S,Metzler-Nolte N

    更新日期:2014-06-01 00:00:00